Q. Mallmann, “The Tension Between “Brand-Name” Drugs And ‘Generics’: The Pharmaceutical Industry’s Temporary Monopoly And The Public Domain – The Legal Regime For Invention Patents”, PIDCC, vol. 15, no. 1, p. e20261501005, Aug. 2026, doi: 10.16928/e20261501005.